MSD has announced plans to start three late-stage studies of Keytruda in patients with metastatic castration-resistant prostate cancer. MSD has announced plans to start three late-stage studies of ...

Oxford, UK-based Adaptimmune has formed a clinical trial pact with MSD to test a potential new combination therapy for multiple myeloma. Oxford, UK-based Adaptimmune has formed a clinical trial pact ...

FOUR people, including the Medical Stores Department (MSD) acting Director General, ignored expert advice and imported faulty HIV testing kits, subjecting the government to suffer an over two million ...